UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Espranor-2mg-Lyophilisate-SE-BS-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-XXXXXXXXX-00051207, http://ema.europa.eu/fhir/eurdId
/461
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Oral lyophilisate
indication:
Substitutionsbehandling för opioidberoende, inom ramen för en medicinsk, social och psykologisk behandling. Behandling med Espranor frystorkad tablett är avsedd för vuxna och ungdomar i åldern 15 år och äldre som har samtyckt till behandling av sitt beroende.
legalStatusOfSupply: Medicinal product subject to special medical prescription
classification: N07BC01
name
productName: Espranor 2 mg frystorkad tablett
part
part: Espranor
type: Invented name part
part
part: 2 mg
type: Strength part
part
part: Frystorkad tablett
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish